Aprogen Medicines Inc

XKRX:007460 (Korea (the Republic of))  
â‚© 1480.00 (-0.13%) May 14
At Loss
P/B:
2.45
Market Cap:
â‚© 361.24B ($ 265.57M)
Enterprise V:
â‚© 444.97B ($ 327.13M)
Volume:
2.44M
Avg Vol (2M):
16.10M
Volume:
2.44M
At Loss
Avg Vol (2M):
16.10M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Aprogen Medicines Inc ( XKRX:007460 ) from 1995 to May 15 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Aprogen Medicines stock (XKRX:007460) PE ratio as of May 15 2024 is 0. More Details

Aprogen Medicines Inc (XKRX:007460) PE Ratio (TTM) Chart

To

Aprogen Medicines Inc (XKRX:007460) PE Ratio (TTM) Historical Data

Total 1264
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Aprogen Medicines PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-15 At Loss 2024-03-08 At Loss
2024-05-14 At Loss 2024-03-07 At Loss
2024-05-13 At Loss 2024-03-06 At Loss
2024-05-10 At Loss 2024-03-05 At Loss
2024-05-09 At Loss 2024-03-04 At Loss
2024-05-08 At Loss 2024-02-29 At Loss
2024-05-07 At Loss 2024-02-28 At Loss
2024-05-03 At Loss 2024-02-27 At Loss
2024-05-02 At Loss 2024-02-26 At Loss
2024-04-30 At Loss 2024-02-23 At Loss
2024-04-29 At Loss 2024-02-22 At Loss
2024-04-26 At Loss 2024-02-21 At Loss
2024-04-25 At Loss 2024-02-20 At Loss
2024-04-24 At Loss 2024-02-19 At Loss
2024-04-23 At Loss 2024-02-16 At Loss
2024-04-22 At Loss 2024-02-15 At Loss
2024-04-19 At Loss 2024-02-14 At Loss
2024-04-18 At Loss 2024-02-13 At Loss
2024-04-17 At Loss 2024-02-08 At Loss
2024-04-16 At Loss 2024-02-07 At Loss
2024-04-15 At Loss 2024-02-06 At Loss
2024-04-12 At Loss 2024-02-05 At Loss
2024-04-11 At Loss 2024-02-02 At Loss
2024-04-09 At Loss 2024-02-01 At Loss
2024-04-08 At Loss 2024-01-31 At Loss
2024-04-05 At Loss 2024-01-30 At Loss
2024-04-04 At Loss 2024-01-29 At Loss
2024-04-03 At Loss 2024-01-26 At Loss
2024-04-02 At Loss 2024-01-25 At Loss
2024-04-01 At Loss 2024-01-24 At Loss
2024-03-29 At Loss 2024-01-23 At Loss
2024-03-28 At Loss 2024-01-22 At Loss
2024-03-27 At Loss 2024-01-19 At Loss
2024-03-26 At Loss 2024-01-18 At Loss
2024-03-25 At Loss 2024-01-17 At Loss
2024-03-22 At Loss 2024-01-16 At Loss
2024-03-21 At Loss 2024-01-15 At Loss
2024-03-20 At Loss 2024-01-12 At Loss
2024-03-19 At Loss 2024-01-11 At Loss
2024-03-18 At Loss 2024-01-10 At Loss
2024-03-15 At Loss 2024-01-09 At Loss
2024-03-14 At Loss 2024-01-08 At Loss
2024-03-13 At Loss 2024-01-05 At Loss
2024-03-12 At Loss 2024-01-04 At Loss
2024-03-11 At Loss 2024-01-03 At Loss

Aprogen Medicines Inc (XKRX:007460) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Aprogen Medicines Inc, formerly Aprogen KIC Inc manufactures and maintains plant equipment for the industrial furnace and oven sector. Its business divisions include plant, fired heater, hard facing, and thermal insulation works.